Corbus Pharmaceuticals Holdings, Inc. Current Assets
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Current Assets of $122.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $122.75M.
- 2026-03-31: Assets, Current $143.57M.
- 2025-12-31: Assets, Current $166.95M.
- 2025-09-30: Assets, Current $107.57M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $122.75M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $143.57M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $166.95M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $107.57M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $122.83M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $137.36M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $152.98M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $160.89M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $148.31M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $121.70M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $23.55M 10-K · filed 2025-03-11 | $23.55M 10-K · filed 2024-03-12 |
| 2023-09-30 | $31.21M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $38.27M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $45.86M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $60.18M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $67.35M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $75.24M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $88.48M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $100.20M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $111.67M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $111.58M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $130.29M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $92.07M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $85.36M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $88.02M 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $54.66M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $38.15M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $57.54M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $75.39M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $92.82M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $44.24M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $58.46M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $67.55M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $74.49M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $65.50M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $38.02M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $44.03M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $50.15M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $17.40M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $19.23M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $22.30M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $10.16M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $12.71M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $13.27M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $9.49M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $5.18M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $6.53M 10-K · filed 2016-03-28 | |
| 2014-09-30 | $7.56M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | $305.52K 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |